Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 392 results for "Cgix" Daily Round Up 3/18/15: DO, ASPS, CGIX, ADMA

Mar. 19, 2015 12:55 PM ET | Includes: ADMA, APHB, ASPS, CGIX, DO, DYN, ENOC, FDS, GGP, MMI, MPW, NEE, PCLN, PSA, RGS, RXDX, SANW, SSNC, TCB, TWTR by: InsiderInsights Summary Tables of the top insider purchases and sales filed with the SEC on ... Seeking Alpha, 1 week ago

2 images for "Cgix"

SleekMoney, 1 week ago
Mideast Time, 2 weeks ago
SPi World News

Cancer Genetics, Inc. to Present Results From Three Major Clinical Research Collaborations at USCAP Showcasing the Importance of Genomic Panels for Cancer Identification and Management

(GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the company") announced today that it will present three posters at USCAP, the annual meeting of the United States and Canadian Academy of Pathology, March 23-24 at the Hynes ...
 Digital Producer1 week ago Cancer Genetics, Inc. (CGIX) in Focus: Stock Jumps 5.3%  Zacks.com2 weeks ago Cancer Genetics' (CGIX) CEO Panna Sharma on Q4 2014 Results - Earnings Call Transcript  Seeking Alpha2 weeks ago Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 12  Individual.com1 month ago

Cancer Genetics Director John Pappajohn Acquires 50,000 Shares (CGIX)

Cancer Genetics (NASDAQ:CGIX) Director John Pappajohn acquired 50,000 shares of Cancer Genetics stock on the open market in a transaction dated Tuesday, March 17th. The stock was purchased at an average cost of $7.36 per share, with a total value of ...
 SleekMoney1 week ago

Insider Trading Disclosures for March, 18th (AER, ANGI, APHB, ARX, ASC, AVX, BAS, CBNJ, CGIX, CSE)

Here is a breakdown of insider trading activity for Wednesday, March 18th: Aimia (TSE:AER) insider Financial Corporation Jaguar purchased 5,000 shares of Aimia stock in a transaction that occurred on Tuesday, March 17th. The shares were purchased ...
 SleekMoney1 week ago

Leading Health Care Stock for Small-Cap Stars is Cancer Genetics Inc. (CGIX) for February 19

Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However,'s Small-Cap Stars , our proprietary list of small-cap companies with ...
 Equities.com1 month ago
Mideast Time

Investment Analysts Ratings Reiterations for March, 15th (AVGR, BIIB, BIOA, CCG, CGIX, CRME, MED, MILL, MONIF, NGVC)

Investment Analysts ratings reiterations for Sunday, March 15th: Avinger (NASDAQ:AVGR) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $18.00 target price on the stock. Avinger (NASDAQ:AVGR) had its ...
 Mideast Time2 weeks ago Cancer Genetics's Buy Rating Reaffirmed at Cantor Fitzgerald (CGIX)  SleekMoney2 weeks ago

Cancer Genetics Sees Strong Trading Volume Following Earnings Beat (CGIX)

Shares of Cancer Genetics (NASDAQ:CGIX) saw strong trading volume on Friday following a stronger than expected earnings report, AR Network reports. 221,503 shares were traded during trading, an increase of 197% from the previous session's volume of ...
 Mideast Time2 weeks ago Cancer Genetics (CGIX) Issues Quarterly Earnings Results  WKRB News2 weeks ago

Zacks: Brokerages Give $14.38 Average Price Target to Cancer Genetics (NASDAQ:CGIX)

Cancer Genetics (NASDAQ:CGIX) has been given an average broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy rating.
 WKRB News2 weeks ago Analysts Set $14.38 Price Target for Cancer Genetics (NASDAQ:CGIX)  Mideast Time1 month ago Analysts Expect Cancer Genetics to Announce ($0.48) EPS (NASDAQ:CGIX)  Ticker Report1 month ago

Vertex Pharma's Disappointing VX-661 Trial Results Isn't The End; Arch Therapeutics Announces Positive Safety Results for AC5 Surgical Hemostatic Device(TM)

Below is a look at some of the headlines for companies that made news in the healthcare sector on March 23, 2015. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares sank Monday on results from a trial of one of its cystic fibrosis ...
 BioMedReports1 week ago Acasti Gains Ahead Of Expected Phase II Results; Cyberonics Plans To Merge With Milan's Sorin SpA  BioMedReports1 month ago Celsus' Lead Drug Flunks Phase II Trial; Acorda Shares Still Down 7% In A Week  BioMedReports1 month ago NeuroBioPharm's Shareholders Approve Arrangement With Neptune; Aileron Initiates Phase 1 Cancer Study of ALRN-6924  BioMedReports1 month ago

Cancer Genetics reports 4Q loss

On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 55 cents. Losses, adjusted for costs related to mergers and acquisitions, came to 49 cents per share. The diagnostics company posted revenue of $4 million in the ...
 Investor's Business Daily2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Cgix
Get updated on latest news & your favorite topics right in your inbox!
More     Less